Showing results (351-360 of 556) with videos related to
Sort By:
Pageof 56
Lung Cancer (Auckland, N.Z.)|January 31, 2018
Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancerVidya H Veldore, Anuradha Choughule, Tejaswi Routhu, et al.South Asian Journal of Cancer|February 9, 2023
Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 InhibitorsAkhil Kapoor, Vanita Noronha, Vijay M Patil, et al.Oral Oncology|December 27, 2025
Prevalence, risk Factors, and quality of life in patients with head and neck lymphedema following treatment for head and neck Cancer: The HeNLy-1 studyShivakumar Thiagarajan, T Rukmangathan, Drub Sharma, et al.Frontiers in Oncology|September 27, 2021
Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in IndiaJyoti Bajpai, George Abraham, Avanish P Saklani, et al.Journal of Neuro-Oncology|January 17, 2022
Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic studyPrithwijit Moitra, Abhishek Chatterjee, Priti Khatri Kota, et al.British Journal of Haematology|December 15, 2023
Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Ankita Pandey, et al.Journal of the Egyptian National Cancer Institute|May 22, 2021
Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositisVanita Noronha, Vijay M Patil, Gunjesh Kumar Singh, et al.Therapeutic Advances in Medical Oncology|September 19, 2022
Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE studyAbdul Rahman Jazieh, Huseyin Cem Onal, Daniel Shao-Weng Tan, et al.Head & Neck|February 26, 2026
Disparity in the Markers of Affordability Across Targeted- and Immune-Therapy Drugs Used in Head and Neck CancersArjun Gurmeet Singh, Labani Kole, Richard Sullivan, et al.The Lancet Regional Health. Southeast Asia|June 9, 2025
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from IndiaManash Pratim Gogoi, Parag Das, Nandana Das, et al.Pageof 56